SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016543
Filing Date
2019-05-07
Accepted
2019-05-07 16:27:49
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20190331.htm 10-Q 1654289
2 EX-31.1 toca-ex311_7.htm EX-31.1 16335
3 EX-31.2 toca-ex312_8.htm EX-31.2 16196
4 EX-32.1 toca-ex321_9.htm EX-32.1 6487
  Complete submission text file 0001564590-19-016543.txt   5778226

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT toca-20190331.xml EX-101.INS 1375137
6 XBRL TAXONOMY EXTENSION SCHEMA toca-20190331.xsd EX-101.SCH 36006
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20190331_cal.xml EX-101.CAL 39482
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20190331_def.xml EX-101.DEF 120433
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20190331_lab.xml EX-101.LAB 287233
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20190331_pre.xml EX-101.PRE 217016
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 19803507
SIC: 2834 Pharmaceutical Preparations